Nafcillin
Nafcillin For Injection, USP
Approved
Approval ID
77999cd2-17b8-4df9-b687-d0f9b62096b9
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Oct 5, 2023
Manufacturers
FDA
WG Critical Care, LLC
DUNS: 829274633
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
NAFCILLIN
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code44567-223
Application NumberANDA090005
Product Classification
M
Marketing Category
C73584
G
Generic Name
NAFCILLIN
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateOctober 5, 2023
FDA Product Classification
INGREDIENTS (3)
NAFCILLIN SODIUMActive
Quantity: 10 g in 100 mL
Code: 49G3001BCK
Classification: ACTIM
NATURAL LATEX RUBBERInactive
Quantity: 0 1 in 100 mL
Code: 2LQ0UUW8IN
Classification: CNTM
SODIUM CITRATE, UNSPECIFIED FORMInactive
Quantity: 400 mg in 100 mL
Code: 1Q73Q2JULR
Classification: IACT